ALTA - Alterola Biotech, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development----
Selling General and Administrative9.54911.63119.88540.915
Non Recurring----
Total Operating Expenses49.13214.73120.40240.915
Operating Income or Loss-49.132-14.731-20.402-40.915
Income from Continuing Operations
Total Other Income/Expenses Net-18.5-7.846-15.725-14
Earnings Before Interest and Taxes-49.132-14.731-20.402-40.915
Interest Expense-18.5-18.019-15.725-14
Income Before Tax-67.632-22.577-36.127-54.915
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-67.632-22.577-36.127-54.915
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-67.632-22.577-36.127-54.915
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-67.632-22.577-36.127-54.915